| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | - | 49.025 | 72.727 | 97.584 |
| Total Income - EUR | - | - | - | - | - | - | - | 49.025 | 72.727 | 97.591 |
| Total Expenses - EUR | - | - | - | - | - | - | - | 49.052 | 67.354 | 95.879 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | - | -27 | 5.373 | 1.712 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | - | -517 | 4.660 | 114 |
| Employees | - | - | - | - | - | - | - | 1 | 1 | 1 |
Check the financial reports for the company - Fda Davidandra Company S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | - | 0 | 0 | 16.283 |
| Current Assets | - | - | - | - | - | - | - | 7.866 | 17.552 | 13.682 |
| Inventories | - | - | - | - | - | - | - | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | - | 0 | 0 | 1.616 |
| Cash | - | - | - | - | - | - | - | 7.866 | 17.552 | 12.065 |
| Shareholders Funds | - | - | - | - | - | - | - | -517 | 4.185 | 4.276 |
| Social Capital | - | - | - | - | - | - | - | 0 | 40 | 40 |
| Debts | - | - | - | - | - | - | - | 8.383 | 13.366 | 25.688 |
| Income in Advance | - | - | - | - | - | - | - | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4941 - 4941" | |||||||||
| CAEN Financial Year |
4941
|
|||||||||
Comments - Fda Davidandra Company S.r.l.